Literature DB >> 2453185

Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Brief report.

A A Thomas1, R J Woortmeijer, S J Barteling, R H Meloen.   

Abstract

Using polyclonal sera raised against foot-and-mouth disease virus in susceptible animals, evidence was obtained for the existence of at least one further important antigenic site in addition to the neutralizing site on VP1 140-160.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2453185     DOI： 10.1007/bf01311072

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  15 in total

1.  An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection.

Authors:  R H Meloen; S J Barteling
Journal:  J Gen Virol       Date:  1986-02       Impact factor: 3.891

Review 2.  Intrinsic and extrinsic factors in protein antigenic structure.

Authors:  J A Berzofsky
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

3.  Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

Authors:  R H Meloen; W C Puyk; D J Meijer; H Lankhof; W P Posthumus; W M Schaaper
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

4.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

5.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

6.  Modulation of humoral response to a 12-amino-acid site on the poliovirus virion.

Authors:  J P Icenogle; P D Minor; M Ferguson; J M Hogle
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

7.  A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.

Authors:  R H Meloen; J Briaire
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

8.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

9.  Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus.

Authors:  J T Stapleton; S M Lemon
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

10.  Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.

Authors:  B Baxt; D O Morgan; B H Robertson; C A Timpone
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103
View more
  8 in total

Review 1.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

2.  Antigenic sites on foot-and-mouth disease virus type A10.

Authors:  A A Thomas; R J Woortmeijer; W Puijk; S J Barteling
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

3.  Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.

Authors:  Kun Li; Yong He; Li Wang; Pinghua Li; Sheng Wang; Pu Sun; Huifang Bao; Yimei Cao; Xuerong Liu; Guoqiang Zhu; Yali Song; Xingwen Bai; Xueqing Ma; Yuanfang Fu; Hong Yuan; Jing Zhang; Jian Wang; Yingli Chen; Dong Li; Zhiyong Lou; Zaixin Liu; Zengjun Lu
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

4.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

5.  The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O.

Authors:  Yan Xiao; Suling Zhang; He Yan; Xiaolin Geng; Yanwei Wang; Xin Xu; Mengyue Wang; Haohao Zhang; Baicheng Huang; Wenqiang Pang; Ming Yang; Kegong Tian
Journal:  Front Vet Sci       Date:  2021-02-25

6.  Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus.

Authors:  Richard Reeve; Belinda Blignaut; Jan J Esterhuysen; Pamela Opperman; Louise Matthews; Elizabeth E Fry; Tjaart A P de Beer; Jacques Theron; Elizabeth Rieder; Wilna Vosloo; Hester G O'Neill; Daniel T Haydon; Francois F Maree
Journal:  PLoS Comput Biol       Date:  2010-12-09       Impact factor: 4.475

7.  Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.

Authors:  Pamela A Opperman; Lia S Rotherham; Jan Esterhuysen; Bryan Charleston; Nicholas Juleff; Alejandra V Capozzo; Jacques Theron; Francois F Maree
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

8.  Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.

Authors:  Ming Yang; Wanhong Xu; Melissa Goolia; Zhidong Zhang
Journal:  Virol J       Date:  2014-08-01       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.